TuHURA Biosciences HURA
NASDAQ HURA
$2.00 -0.22 (-9.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

TuHURA Biosciences (HURA) Non-Current Assets (2015 - 2026)

TuHURA Biosciences (HURA) posted quarterly Non-Current Assets of $22.7 million for Q1 2026, up 7152.7% year-over-year from $313297.0 in Q1 2025, and little changed quarter-over-quarter from $22.7 million in Q4 2025.

TuHURA Biosciences (HURA) Non-Current Assets (2015 - 2026) Analysis & Trends

TuHURA Biosciences' Non-Current Assets history runs 12 years deep, the most recent figure standing at $22.7 million for Q1 2026.

  • In Q1 2026, Non-Current Assets rose 7152.7% year-over-year to $22.7 million; the TTM figure through Mar 2026 stood at $89.7 million (up 4385.15% YoY), while the FY2025 annual figure was $22.7 million, up 6280.11% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $22.7 million, roughly flat from $22.7 million in the prior quarter.
  • The five-year high for Non-Current Assets was $22.7 million in Q4 2025, with the low at $202990.0 in Q4 2023.
  • The 5-year median for Non-Current Assets is $724000.0 (2023), against an average of $6.2 million.
  • The sharpest annual moves came in 2023 and 2026: Non-Current Assets sank 86.27% in 2023, then surged 7152.7% in 2026.
  • TuHURA Biosciences' Non-Current Assets stood at $739000.0 in 2022, then slumped by 72.53% to $202990.0 in 2023, then soared by 75.52% to $356295.0 in 2024, then surged by 6280.11% to $22.7 million in 2025, then decreased by 0.04% to $22.7 million in 2026.
  • Business Quant data shows HURA's Non-Current Assets at $22.7 million in Q1 2026, $22.7 million in Q4 2025, and $22.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 14.88 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 23.28 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.15 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.96 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 938.60 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 468.65 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 18.06 Bn
10 TuHURA Biosciences 37.61 Mn 37.61 Mn - 30.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 22.72 Mn
Dec 31, 2025 22.73 Mn
Sep 30, 2025 22.19 Mn
Jun 30, 2025 22.08 Mn
Mar 31, 2025 313,297.00
Dec 31, 2024 356,295.00
Sep 30, 2024 657,000.00
Jun 30, 2024 674,000.00
Mar 31, 2024 691,000.00
Dec 31, 2023 202,990.00
Sep 30, 2023 694,000.00
Jun 30, 2023 709,000.00
Mar 31, 2023 724,000.00
Dec 31, 2022 739,000.00
Sep 30, 2022 5.05 Mn
Jun 30, 2022 2.69 Mn
Mar 31, 2022 2.71 Mn
Dec 31, 2021 2.72 Mn
Sep 30, 2021 2.24 Mn
Jun 30, 2021 1.75 Mn